Zhao Daiguo, Zhang Mingjie, Li Zhen, Lan Wanling, Meng Mingjiang, Tan Hong
() ( 611731) Sichuan Provincial Institute for Drug Control (Sichuan Medical Device Testing Center), Chengdu 611731, China.
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Jul 20;55(4):807-812. doi: 10.12182/20240760401.
Medical polyurethanes have emerged as a leading choice for biomedical applications owing to their exceptional biocompatibility and good physical and mechanical properties. Catalysts play a crucial role as additives in the synthesis of medical polyurethanes, enhancing synthesis efficiency and material properties. However, the catalysts used may affect the biocompatibility of polyurethanes and pose potential harm to human health. This review encapsulates the latest findings regarding the catalysts employed in the synthesis of medical polyurethane materials and their biotoxicity. Initially, we reviewed the prevalent types of catalysts used in the synthesis of medical polyurethane materials and described their distinctive characteristics. Subsequently, our focus shifted to exploring the potential biotoxicity associated with these catalysts. Finally, we provided a forward-looking perspective and recommendations for the future trajectory of catalyst selection in the synthesis of medical polyurethane materials. By acquiring a more profound understanding of the properties and biotoxicity of catalysts used in the synthesis of medical polyurethane materials, and by uncovering existing issues and challenges, we can better guide the design of medical polyurethane materials. This, in turn, enables us to chart the course for future development and ultimately enhance the biocompatibility and safety profiles of medical polyurethane materials. Such advancements will promote the continued development and application of medical polyurethane materials in clinical settings.
由于其卓越的生物相容性以及良好的物理和机械性能,医用聚氨酯已成为生物医学应用的首选材料。催化剂作为添加剂在医用聚氨酯的合成中起着至关重要的作用,可提高合成效率和材料性能。然而,所使用的催化剂可能会影响聚氨酯的生物相容性,并对人体健康构成潜在危害。本综述总结了关于医用聚氨酯材料合成中所用催化剂及其生物毒性的最新研究结果。首先,我们回顾了医用聚氨酯材料合成中常用的催化剂类型,并描述了它们的独特特性。随后,我们将重点转向探索与这些催化剂相关的潜在生物毒性。最后,我们对医用聚氨酯材料合成中催化剂选择的未来发展方向提供了前瞻性的观点和建议。通过更深入地了解医用聚氨酯材料合成中所用催化剂的性质和生物毒性,并揭示现有问题和挑战,我们可以更好地指导医用聚氨酯材料的设计。这反过来又使我们能够规划未来的发展方向,并最终提高医用聚氨酯材料的生物相容性和安全性。这些进展将促进医用聚氨酯材料在临床环境中的持续发展和应用。